Cargando…

A Comprehensive Review and Perspective on Natural Sources as Dipeptidyl Peptidase-4 Inhibitors for Management of Diabetes

Type 2 diabetes mellitus (T2DM) is an increasing global public health problem, and its prevalence is expected to rise in coming decades. Dipeptidyl peptidase-4 (DPP-4) is a therapeutic target for the management of T2DM, and its inhibitors prevent the degradation of glucose-dependent insulinotropic p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaikh, Sibhghatulla, Lee, Eun-Ju, Ahmad, Khurshid, Ahmad, Syed-Sayeed, Lim, Jeong-Ho, Choi, Inho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235117/ https://www.ncbi.nlm.nih.gov/pubmed/34203048 http://dx.doi.org/10.3390/ph14060591

Ejemplares similares

Dipeptidyl peptidase-4 inhibitory potentials of Glycyrrhiza uralensis and its bioactive compounds licochalcone A and licochalcone B: An in silico and in vitro study
por: Shaikh, Sibhghatulla, et al.
Publicado: (2022)

Computational Identification of Dithymoquinone as a Potential Inhibitor of Myostatin and Regulator of Muscle Mass
por: Ahmad, Syed Sayeed, et al.
Publicado: (2021)

Identification and Evaluation of Traditional Chinese Medicine Natural Compounds as Potential Myostatin Inhibitors: An In Silico Approach
por: Ali, Shahid, et al.
Publicado: (2022)

Biocomputational Screening of Natural Compounds against Acetylcholinesterase
por: Ahmad, Syed Sayeed, et al.
Publicado: (2021)

Extracellular matrix: the critical contributor to skeletal muscle regeneration—a comprehensive review
por: Ahmad, Khurshid, et al.
Publicado: (2023)

Cross-Talk Between Extracellular Matrix and Skeletal Muscle: Implications for Myopathies
por: Ahmad, Khurshid, et al.
Publicado: (2020)

Natural Products in Therapeutic Management of Multineurodegenerative Disorders by Targeting Autophagy
por: Shaikh, Sibhghatulla, et al.
Publicado: (2021)

MIF1 and MIF2 Myostatin Peptide Inhibitors as Potent Muscle Mass Regulators
por: Lee, Eun Ju, et al.
Publicado: (2022)

Extracellular Matrix and the Production of Cultured Meat
por: Ahmad, Khurshid, et al.
Publicado: (2021)

Virtual Insights into Natural Compounds as Potential 5α-Reductase Type II Inhibitors: A Structure-Based Screening and Molecular Dynamics Simulation Study
por: Shaikh, Sibhghatulla, et al.
Publicado: (2023)

Cell Types Used for Cultured Meat Production and the Importance of Myokines
por: Shaikh, Sibhghatulla, et al.
Publicado: (2021)

Molecular Mechanisms and Current Treatment Options for Cancer Cachexia
por: Ahmad, Syed Sayeed, et al.
Publicado: (2022)

New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
por: Cui, Chenkai, et al.
Publicado: (2022)

Interaction of Fibromodulin and Myostatin to Regulate Skeletal Muscle Aging: An Opposite Regulation in Muscle Aging, Diabetes, and Intracellular Lipid Accumulation
por: Lee, Eun Ju, et al.
Publicado: (2021)

Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies
por: Baig, Mohammad Hassan, et al.
Publicado: (2022)

The roles of growth factors and hormones in the regulation of muscle satellite cells for cultured meat production
por: Ahmad, Syed Sayeed, et al.
Publicado: (2023)

Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor
por: Nojima, Hiroyuki, et al.
Publicado: (2016)

Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals
por: Davis, Joseph A., et al.
Publicado: (2010)

Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors
por: Shibasaki, Ikuko, et al.
Publicado: (2022)

Mechanistic Insights into the Antimicrobial Actions of Metallic Nanoparticles and Their Implications for Multidrug Resistance
por: Shaikh, Sibhghatulla, et al.
Publicado: (2019)

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
por: Kim, Na-Hyung, et al.
Publicado: (2014)

Angioedema associated with dipeptidyl peptidase-IV inhibitors
por: Cassano, Nicoletta, et al.
Publicado: (2021)

Renoprotective Effect of a Dipeptidyl Peptidase-4 Inhibitor on Aging Mice
por: Ban, Tae H, et al.
Publicado: (2019)

Computational Analysis of Gynura bicolor Bioactive Compounds as Dipeptidyl Peptidase-IV Inhibitor
por: Rozano, Lina, et al.
Publicado: (2017)

Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
por: Jang, Yun-Mi, et al.
Publicado: (2011)

Health economic evaluation of dipeptidyl peptidase-4 inhibitors
por: Garg, Vishvas
Publicado: (2011)

Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions
por: Singh, Awadhesh Kumar
Publicado: (2014)

Navigating the chemical space of dipeptidyl peptidase-4 inhibitors
por: Shoombuatong, Watshara, et al.
Publicado: (2015)

Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Outcome
por: Kim, Kwang-il
Publicado: (2018)

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
por: Tasanen, Kaisa, et al.
Publicado: (2019)

Dipeptidyl peptidase 4 inhibitors: Applications in innate immunity?
por: Yazbeck, R., et al.
Publicado: (2021)

Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment
por: Yin, Ruili, et al.
Publicado: (2022)

Isolation and Characterization of Compounds from Glycyrrhiza uralensis as Therapeutic Agents for the Muscle Disorders
por: Lee, Eun Ju, et al.
Publicado: (2021)

IgLON5 Regulates the Adhesion and Differentiation of Myoblasts
por: Lim, Jeong Ho, et al.
Publicado: (2021)

The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
por: Kanasaki, Keizo
Publicado: (2018)

Dermatopontin in Skeletal Muscle Extracellular Matrix Regulates Myogenesis
por: Kim, Taeyeon, et al.
Publicado: (2019)

Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes
por: Singh, Anand-Krishna, et al.
Publicado: (2021)

Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs
por: Mashraqi, Mutaib M., et al.
Publicado: (2021)

Correction: The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
por: Kanasaki, Keizo
Publicado: (2019)

Increasing Age Associated with Higher Dipeptidyl Peptidase-4 Inhibition Rate Is a Predictive Factor for Efficacy of Dipeptidyl Peptidase-4 Inhibitors
por: Hong, Sangmo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l09nnp2lme9v76r7rhd85e0dc1